SCHEMBL30808155

SCHEMBL30808155

COC(=O)c1ccccc1NC(C)c1cc(C)cc2ncc(N3CCN(c4ccccc4F)CC3)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ AKT1 P31749 4/20 0.47
▸ AKT2 P31751 4/20 0.47
▸ AKT3 Q9Y243 4/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 4/20 0.46
▸ LMNA P02545 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ NFKB2 Q00653 1/20 0.44
▸ RELA Q04206 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ PIK3CA P42336 7/20 0.41
▸ PIK3CB P42338 6/20 0.40
▸ PIK3CD O00329 5/20 0.40
▸ PIK3CG P48736 5/20 0.40
▸ MTOR P42345 3/20 0.40
▸ SRC P12931 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30808158 0.92 AKT1 (0.56) AKT1AKT2AKT3MAPTLMNA
SCHEMBL30808169 0.87 PIK3CB (0.53) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30808195 0.80 AKT1 (0.67) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30808186 0.80 AKT1 (0.67) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30808212 0.80 AKT1 (0.67) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30808187 0.80 AKT1 (0.71) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30808170 0.80 AKT1 (0.71) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30808161 0.78 PIK3CA (0.64) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30808153 0.78 PIK3CA (0.64) AKT1AKT2AKT3PIK3CAPIK3CB
SCHEMBL30808204 0.78 PIK3CA (0.64) AKT1AKT2AKT3PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026419-A1 QUINOXALINE DERIVATIVES AS PIK3 ALPHA MODULATORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback